Cathie Wood’s Bold Move: 8 Straight Days Of Buying Beam Therapeutics As Stock Soars 14%

Cathie Wood is back in the spotlight, and so is her flagship ARK Innovation ETF (NYSE:ARKK). After a rough year, the fund is showing signs of life—but is this the start of a real comeback, or just another short-lived rally? Investors are split, and the numbers tell an interesting story.

ARKK’s Rebound, Skeptics, and the High-Stakes Bet on Innovation

So far this year, ARKK is up 6%—a solid lead over the S&P 500’s 2% gain and the Nasdaq’s 1% increase. That’s a welcome shift after 2024, when ARKK returned 12%—not bad, but nowhere near the S&P 500’s 24% surge.

Don’t Miss:

• The $1.3 Billion Startup Investment Boom: How This Company’s Explosive Growth Is Opening Doors For Everyday Investors With A New $500 Minimum
• ‘Scrolling To UBI’ — Deloitte’s #1 fastest-growing software company allows users to earn money on their phones. You can invest today for just $0.26/share with a $1000 minimum.

Looking at the bigger picture, ARKK’s longer-term numbers tell a more complicated story. Over the past three years, its annualized return is -5.89%, …

Full story available on Benzinga.com